The purpose of the company is to engage in research, development, and the creation, acquisition, and marketing of intellectual property (IP) for differentiated, innovative, and generic pharmaceutical formulations. The company's purpose includes the development of injectable, oral, ophthalmological, and novel drug delivery systems, as well as the compilation and maintenance of regulatory documents such as Drug Master Files (DMFs) and Common Technical Documents (CTDs). The company can license or transfer such documents, technologies, and IP to commercial partners worldwide through strategic alliances, technology transfers, and licensing agreements. The company may participate in other ventures, acquire, exploit, manage, and dispose of real estate, establish subsidiaries and branches both domestically and abroad, and perform all legal acts that may be associated with the company's purpose or that are suitable to promote its development or that of group companies. The company may provide direct or indirect financing to third parties, including companies in which it is directly or indirectly involved, its direct or indirect shareholders, and companies in which these shareholders are directly or indirectly involved, either through loans or other financing arrangements, including under cash pooling agreements, and may also provide securities of any kind for their liabilities, including by pledging or fiduciary transfer of the company's assets or by providing guarantees of any kind, with or without compensation.
Outbound Leads by COHAGA